Reassessing Routine Postoperative Imaging in Acromegaly: Insights from a Cohort with Biochemical Remission

Read full text Summarise with VIRAT
Authors: Jelena Maletkovic, Marvin Bergsneider, Won Kim, Marilene B. Wang, Jeffrey D. Suh, Michael Linetsky, Noriko Salamon, Sandra Pekić, Anthony P. Heaney
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Postoperative evaluation for growth hormone-producing pituitary tumors entails assessing remission via biochemical markers alongside MRI to detect residual tumors. While postoperative imaging provides important anatomical information regarding potential residual tumor, it is reasonable to ask if imaging offers largely redundant data when biochemical remission is already established. This study aimed to determine the clinical utility of post-surgical surveillance imaging in patients who achieved biochemical remission with normal age- and sex-matched IGF-1 at ~3 months postoperatively. Furthermore, we sought to evaluate the long-term durability of biochemical control in this patient subset. Methods: We conducted a retrospective analysis on patients who underwent endoscopic endonasal approach surgery for acromegaly and had a minimum of 3 years of follow-up clinical, biochemical and imaging data. Results: In total, 15 of 28 patients (54%) achieved initial biochemical remission and had a 100% sustained remission rate during the follow-up period of 3–14 years, underscoring the importance of surgical radicality for achieving durable remission. Conclusions: Our findings suggest that for patients who achieved biochemical remission following transsphenoidal surgery for acromegaly, routine postoperative imaging provides negligible additional diagnostic information from an endocrinological perspective. As such, we propose that no further postoperative imaging is needed for patients in clinical and biochemical remission. This approach offers a significant reduction in the clinical burden and healthcare costs for patients associated with long-term management of their disease.

Fields of Study & Subjects

Pituitary Gland Disorders and Treatments Neuroendocrine Tumor Research Advances Head and Neck Surgical Oncology

Publication details

Journal / source
Surgeries
Volume
7
Issue
2
Pages
43–43
Publication date
26 March 2026
Language
EN